Robert Roos | News Editor | CIDRAP NewsOct 27, 2014The $375 million deal will make the company the second leading player in the $4 billion global flu vaccine market.Share Tweet LinkedIn Email Print & PDF
Robert Roos | News Editor | CIDRAP News
Oct 27, 2014
The $375 million deal will make the company the second leading player in the $4 billion global flu vaccine market.
